Biomarin Pharmaceutical Inc (BMRN)
Operating return on assets (Operating ROA)
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 158,097 | 149,562 | -82,341 | -43,440 | -100,457 |
| Total assets | US$ in thousands | 6,841,600 | 6,375,070 | 6,004,770 | 5,848,020 | 4,690,040 |
| Operating ROA | 2.31% | 2.35% | -1.37% | -0.74% | -2.14% |
December 31, 2023 calculation
Operating ROA = Operating income ÷ Total assets
= $158,097K ÷ $6,841,600K
= 2.31%
Biomarin Pharmaceutical Inc's operating return on assets (operating ROA) has shown fluctuating performance over the past five years. In 2023, the operating ROA stood at 2.31%, a slight decrease from the previous year's figure of 2.35%. This indicates that the company generated $2.31 in operating income for every $100 of assets it holds.
Looking back, Biomarin Pharmaceutical Inc experienced a significant improvement in its operating ROA in 2021, rebounding from negative figures in the two preceding years. The return on assets was recorded at -1.37% in 2021, compared to -0.74% in 2020 and -2.14% in 2019.
The positive operating ROA in 2021 suggests that the company was able to effectively generate operating income relative to its asset base, indicating improved operational efficiency or asset utilization compared to the previous years.
Overall, Biomarin Pharmaceutical Inc's operating ROA performance has been volatile in the recent years, underscoring the importance of closely monitoring and analyzing factors that influence the company's profitability and asset management strategies.
Peer comparison
Dec 31, 2023